RETRACTABLE TECHNOLOGIES INC — Form 8-K
Filed November 16, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 72/100
What the filing says
Retractable Technologies reported Q3 2026 net sales of $14.1M (vs. $10.1M prior year), a 39% increase driven by EasyPoint needle sales timing and higher unit volumes (+64%). However, operating losses expanded to $4.1M from $3.7M due to unfavorable product mix (shift to lower-margin EasyPoint needles). Nine-month 2026 results show flat revenue ($28.5M vs. $28.8M) but widening operating losses ($15.5M vs. $13.5M), partially offset by a $6.4M realized gain on equity security sales. The company reduced tariff exposure via 40.3% domestic production and strategic sourcing, spending $318K on tariffs in nine months.
Why this rating
Revenue growth masks margin deterioration; operating losses 15–21% of company market cap. Tariff mitigation and cost actions positive, but product mix headwind and liquidity concerns material to $8.1M firm.
Tradability signal
NO TRADE
No trade: only ~$10k traded in the last 30 min — too illiquid to enter and exit.
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it negative)
before filing · preread $0.56 ▲ 0.00% | at our read · unknown $0.56 | +10 min · unknown $0.56 ▲ 0.02% | +30 min · unknown $0.56 ▲ 0.27% | +1 hr · unknown $0.56 ▲ 0.38% | +4 hrs · unknown $0.56 ▲ 0.38% |
The stock had already moved -0.00% between hitting EDGAR and our read finishing — deltas above are measured from our read.
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from November 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.